BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33965440)

  • 21. The critical size of gold nanoparticles for overcoming P-gp mediated multidrug resistance.
    Jiang Y; Wang Z; Duan W; Liu L; Si M; Chen X; Fang CJ
    Nanoscale; 2020 Aug; 12(31):16451-16461. PubMed ID: 32790812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATP-dependent activity and mitochondrial localization of drug efflux pumps in doxorubicin-resistant breast cancer cells.
    Dartier J; Lemaitre E; Chourpa I; Goupille C; Servais S; Chevalier S; Mahéo K; Dumas JF
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1075-1084. PubMed ID: 28214549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells.
    Cui Q; Cai CY; Wang JQ; Zhang S; Gupta P; Ji N; Yang Y; Dong X; Yang DH; Chen ZS
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31443367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance.
    Wang H; Gao Z; Liu X; Agarwal P; Zhao S; Conroy DW; Ji G; Yu J; Jaroniec CP; Liu Z; Lu X; Li X; He X
    Nat Commun; 2018 Feb; 9(1):562. PubMed ID: 29422620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
    Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
    Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of P-glycoprotein-mediated multidrug resistance by novel curcumin analogues in paclitaxel-resistant human breast cancer cells.
    Gao L; Zhao P; Li Y; Yang D; Hu P; Li L; Cheng Y; Yao H
    Biochem Cell Biol; 2020 Aug; 98(4):484-491. PubMed ID: 31967866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucosamine Reverses P-Glycoprotein-Mediated Multidrug Resistance in the Daunorubicin-Resistant Human Gastric Cancer Cells.
    Valinezhad Sani F; Mosaffa F; Jamialahmadi K; Palizban A
    Nutr Cancer; 2020; 72(3):522-527. PubMed ID: 31290701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folate-Gold-Bilirubin Nanoconjugate Induces Apoptotic Death in Multidrug-Resistant Oral Carcinoma Cells.
    Rathinaraj P; Muthusamy G; Prasad NR; Gunaseelan S; Kim B; Zhu S
    Eur J Drug Metab Pharmacokinet; 2020 Apr; 45(2):285-296. PubMed ID: 31858458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marine Natural Products as Models to Circumvent Multidrug Resistance.
    Long S; Sousa E; Kijjoa A; Pinto MM
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27399665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of endogenous multidrug resistance 1 and P-glycoprotein expression on anticancer drug resistance in colon cancer cell lines.
    Washio I; Nakanishi T; Ishiguro N; Bister B; Tamai I
    Biopharm Drug Dispos; 2019 Jan; 40(1):32-43. PubMed ID: 30556139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
    Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
    Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency.
    Vahedi S; Chufan EE; Ambudkar SV
    Biochem Pharmacol; 2017 Nov; 143():53-64. PubMed ID: 28728917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substrate-induced conformational changes in the nucleotide-binding domains of lipid bilayer-associated P-glycoprotein during ATP hydrolysis.
    Zoghbi ME; Mok L; Swartz DJ; Singh A; Fendley GA; Urbatsch IL; Altenberg GA
    J Biol Chem; 2017 Dec; 292(50):20412-20424. PubMed ID: 29018094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efflux mechanism and pathway of verapamil pumping by human P-glycoprotein.
    Wang L; Sun Y
    Arch Biochem Biophys; 2020 Dec; 696():108675. PubMed ID: 33197430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The phenothiazine, trifluoperazine, is selectively lethal to ABCB1-expressing multidrug resistant cells.
    Limniatis G; Georges E
    Biochem Biophys Res Commun; 2021 Sep; 570():148-153. PubMed ID: 34284140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
    Doyle L; Ross DD
    Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zhankuic Acids A, B and C from
    Teng YN; Wang YH; Wu TS; Hung HY; Hung CC
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31766413
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1).
    Sajid A; Raju N; Lusvarghi S; Vahedi S; Swenson RE; Ambudkar SV
    Drug Metab Dispos; 2019 Oct; 47(10):1013-1023. PubMed ID: 31371421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of P-glycoprotein by natural products in human breast cancer cells.
    Chung SY; Sung MK; Kim NH; Jang JO; Go EJ; Lee HJ
    Arch Pharm Res; 2005 Jul; 28(7):823-8. PubMed ID: 16114498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.